Regen BioPharma Inc (RGBP)
0.57
-0.01
(-0.89%)
USD |
OTCM |
May 02, 15:49
Regen BioPharma 1 Year Total Returns (Daily): -66.76% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -66.76% |
April 30, 2024 | -62.06% |
April 29, 2024 | -57.93% |
April 26, 2024 | -65.00% |
April 25, 2024 | -65.09% |
April 24, 2024 | -64.42% |
April 23, 2024 | -66.98% |
April 22, 2024 | -66.98% |
April 19, 2024 | -68.95% |
April 18, 2024 | -69.30% |
April 17, 2024 | -70.88% |
April 16, 2024 | -71.02% |
April 15, 2024 | -67.17% |
April 12, 2024 | -59.77% |
April 11, 2024 | -67.27% |
April 10, 2024 | -66.95% |
April 09, 2024 | -67.89% |
April 08, 2024 | -65.79% |
April 05, 2024 | -64.00% |
April 04, 2024 | -60.00% |
April 03, 2024 | -60.35% |
April 02, 2024 | -61.54% |
April 01, 2024 | -67.18% |
March 28, 2024 | -60.73% |
March 27, 2024 | -65.18% |
Date | Value |
---|---|
March 26, 2024 | -62.50% |
March 25, 2024 | -63.56% |
March 22, 2024 | -63.47% |
March 21, 2024 | -67.11% |
March 20, 2024 | -63.21% |
March 19, 2024 | -68.22% |
March 18, 2024 | -70.25% |
March 15, 2024 | -41.55% |
March 14, 2024 | -51.88% |
March 13, 2024 | -55.29% |
March 12, 2024 | -59.39% |
March 11, 2024 | -61.16% |
March 08, 2024 | -63.21% |
March 07, 2024 | -62.52% |
March 06, 2024 | -58.10% |
March 05, 2024 | -69.82% |
March 04, 2024 | -72.35% |
March 01, 2024 | -69.47% |
February 29, 2024 | -60.60% |
February 28, 2024 | -60.25% |
February 27, 2024 | -59.07% |
February 26, 2024 | -59.78% |
February 23, 2024 | -63.55% |
February 22, 2024 | -70.17% |
February 21, 2024 | -70.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.95%
Minimum
Mar 12 2020
3.93M%
Maximum
Apr 15 2021
7.86K%
Average
-72.82%
Median
Dec 14 2022
1 Year Total Returns (Daily) Benchmarks
CervoMed Inc | 303.7% |
GlucoTrack Inc | 44.43% |
AIM ImmunoTech Inc | -15.22% |
Protalix BioTherapeutics Inc | -58.28% |
Armata Pharmaceuticals Inc | 54.84% |